Amending for N,N-dimethylformamide in Annex XVII to REACH Regulation
Europe
Amending for N,N-dimethylformamide in Annex XVII to REACH Regulation
On 22nd November 2021, the European Union (EU) published Regulation (EU) No 2021/2030 with an amendment to Annex XVII of REACH as regards N,N-dimethylformamide, which entered in force on 9th December 2021.
N,N-dimethylformamide (CAS No 68-12-2) was added as Entry 76 in Annex XVII to Regulation (EC) No 1907/2006 with the following restrictions:
- Shall not be placed on the market as a substance on its own, as a constituent of other substances, or in mixtures in a concentration equal to or greater than 0.3 % after 12 December 2023 unless manufacturers, importers and downstream users have included in the relevant chemical safety reports and safety data sheets, Derived No-Effect Levels (DNELs) relating to exposure of workers of 6 mg/m3 for exposure by inhalation and 1.1 mg/kg/day for dermal exposure.
- Shall not be manufactured, or used, as a substance on its own, as a constituent of other substances, or in mixtures in a concentration equal to or greater than 0.3% after 12 December 2023 unless manufacturers and downstream users take the appropriate risk management measures and provide the appropriate operational conditions to ensure that exposure of workers is below the DNELs specified in paragraph 1.
By way of derogation from paragraphs 1 and 2, the obligations laid down therein shall apply from 12 December 2024 in relation to placing on the market for use as a solvent in direct or transfer polyurethane coating processes of textiles and paper material or the production of polyurethane membranes, and from 12 December 2025 in relation to placing on the market for use as a solvent in the dry and wet spinning processes of synthetic fibres.
